Skip to content

A Preliminary study on Safety and Efficacy confirmation of a specific Wat Pho Thai Herbal medicine in Persistent Allergic rhinitis: A Randomized Double-Blind Placebo-controlled trial

A Preliminary study on Safety and Efficacy confirmation of a specific Wat Pho Thai Herbal medicine in Persistent Allergic rhinitis: A Randomized Double-Blind Placebo-controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20150123003
Enrollment
44
Registered
2015-01-23
Start date
2015-02-15
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

boold evaluation after treatment as the same placebo group. Adverse events evaluation found mild diarrhea symptom score of allergic rhinitis improvement 3 symptoms Nasal cogestion improvement Thai herbal medicine allergic rhinitis Thai traditional medicine

Interventions

Oral Thai herbal medicine 2 capsules three times a day after breakfast&#44
lunch and dinner
Oral Thai herbal medicine

Sponsors

The Thai traditional Medicine Knowledge Fund
Lead Sponsor
Faculty of Medicine Mahasarakham University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Persistent allergic rhinitis patients who get severity of the disease since mild and moderate to severe 2. Aged over 18 years. 3. Understanding of the project details and signing into informed consent form

Exclusion criteria

Exclusion criteria: 1. Persistent allergic rhinitis patients who are concurrently taking anti-histamines or steroids and not willing to interrupt the drugs. 2. Patients who are addicted to alcohol or illegal drugs, which could affect the assessment of symptoms and quality of life of the study. 3. Patients who are participating other ongoing project(s) and required to continue study medication . 4. Having chronic diseases which may effect the results of symptom scores and quality of life assessment. 5. Concurrently taking herbal medicine which is a component of the trial. 6. If female, pregnant or in lactation or planning to become pregnant within 6 months. 7. Subjects have history of allergy to any herbal medicine in the study regimen

Design outcomes

Primary

MeasureTime frame
Safety 1 month blood evaluation,Safety 1 month blood evaluation

Secondary

MeasureTime frame
Efficacy 1 month physician evaluation, Symptoms assessment , Evaluate quality of life

Countries

Thailand

Contacts

Public ContactPunnee Pitisuttithum

none

tmppt@mahidol.ac.th08-1829-4906

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026